(Q44701980)

5 December 2017

1 reference

title

Therapy of severe fungal infections (English)

1 reference

5 December 2017

1

M Battegay

1 reference

5 December 2017

U Flückiger

2

1 reference

PubMed ID

14689198

5 December 2017

language of work or name

German

0 references

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

44

1 reference

5 December 2017

12

1 reference

5 December 2017

1549-1556

1 reference

5 December 2017

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice

1 reference

12 December 2020

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

1 reference

12 December 2020

Caspofungin versus amphotericin B for the treatment of Candidal esophagitis

1 reference

12 December 2020

Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

1 reference

12 December 2020

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

12 December 2020

Aspergillosis. Pathogenesis, clinical manifestations, and therapy

1 reference

12 December 2020

Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America

1 reference

12 December 2020

The treatment of pulmonary aspergilloma.

1 reference

12 December 2020

Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators

1 reference

12 December 2020

Invasive aspergillosis in 2002: an update

1 reference

12 December 2020

Invasive Aspergillus infections in hematologic malignancy patients

1 reference

12 December 2020

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

12 December 2020

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

1 reference

12 December 2020

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

12 December 2020

What's New in Antifungals?

1 reference

12 December 2020

Caspofungin in the treatment of oropharyngeal candidiasis.

1 reference

12 December 2020

Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Diagnosis of fungal infections: current status

1 reference

12 December 2020

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

12 December 2020

Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole

1 reference

12 December 2020

Invasive oesophageal candidiasis: current and developing treatment options

1 reference

12 December 2020

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

12 December 2020

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

12 December 2020

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

12 December 2020

Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans

1 reference

12 December 2020

1 reference

12 December 2020

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods

1 reference

12 December 2020

Antifungal chemotherapy: advances and perspectives.

1 reference

12 December 2020

1 reference

12 December 2020

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

1 reference

12 December 2020

Caspofungin: new preparation. A last resort in invasive aspergillosis

1 reference

12 December 2020

Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent

1 reference

12 December 2020

Fungal infections in the recipients of solid organ transplantation

1 reference

12 December 2020

Deeply invasive candidiasis

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

1 reference

12 December 2020

Caspofungin: an echinocandin antifungal agent

1 reference

12 December 2020

Management of mycoses in patients with hematologic disease and cancer -- review of the literature.

1 reference

12 December 2020

Fungal infections in nontransplant patients with hematologic malignancies

1 reference

12 December 2020

Antifungal therapy--state of the art at the beginning of the 21st century.

1 reference

12 December 2020

Is 24 hours infusion of amphotericin B deoxycholate as good as liposomal amphotericin B?

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus

1 reference

12 December 2020

Emerging and less common fungal pathogens

1 reference

12 December 2020

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

12 December 2020

Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin

1 reference

12 December 2020

Voriconazole: a new triazole antifungal agent

1 reference

12 December 2020

10.1007/S00108-003-1065-7

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14689198